Expert Interview
Discussing the potential of rocatinlimab, an investigational therapy targeting the OX40 receptor, for adults with moderate to severe atopic dermatitis and the recently announced top-line results of the Phase 3 ROCKET HORIZON trial.
Ticker(s): KYKOF, AMGNInstitution: Alliance Dermatology
Dr. Nguyen is from Baton Rouge, Louisiana. He completed his undergraduate studies at Louisiana State University where he received a Bachelor of Science degree with honors.
After college, he attended medical school at LSU School of Medicine in New Orleans. Prior to starting his dermatology residency, he successfully completed his internship at Charity Hospital. Dr. Nguyen completed his training with the LSU Department of Dermatology in New Orleans. He served as chief resident during his final year of residency
Dr. Nguyen received his board certification by the American Board of Dermatology in 2005.
He is a Diplomate of the American Board of Dermatology and he is a Fellow of the American Academy of Dermatology.
Dr. Nguyen was in private practice in Arlington, Texas for 5 years before starting Alliance Dermatology.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
